Mesenchymal Stem Cells to Treat Ischemic Cardiomyopathy

Status Completed

Clinical Trial Summary

This study will evaluate the safety and efficacy of intracoronary injection of mesenchymal stem cells (MSCs) to repair heart function in patients with myocardial ischemia.

Clinical Trial Description

Ischemic heart disease is a major public health problem in the industrialized and developing world. Current research is focusing on the development of cell-based therapies using stem cells to treat heart failure. Mesenchymal stem cells (MSCs) can differentiate into endothelial cells and participate in the development of new blood vessels in the heart damaged. Therefore, MSCs has shown promise for heart repair. The investigators study will evaluate the safety and efficacy of intracoronary injection of mesenchymal stem cells (MSCs) to repair heart function in patients with myocardial ischemia. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT01913886
Study type	Interventional
Source	Pontifícia Universidade Católica do Paraná
Contact
Status	Completed
Phase	Phase 1/Phase 2
Start date	January 2010
Completion date	March 2016

View Details

See also
Status	Clinical Trial	Phase
Terminated	`NCT04066738` - Scar Location and Acute Haemodynamic Response to MultiPoint Pacing Study in Patients With Ischemic Cardiomyopathy	N/A
Recruiting	`NCT03536052` - Ablation at Virtual-hEart pRedicted Targets for VT	N/A
Enrolling by invitation	`NCT02930265` - Clinical Study of Liraglutide in Improving Cardiac Function for Patients With Ischemic Cardiomyopathy	N/A
Completed	`NCT01215253` - Ranolazine Implantable Cardioverter-Defibrillator Trial	Phase 3
Completed	`NCT04508608` - Scintigraphic Evaluation of Contractile and Coronary Reserve in Patients With Ischemic Cardiomyopathy
Recruiting	`NCT05888662` - Endo-epicardial vs Endocardial-only Catheter Ablation of Ventricular Tachycardia in Patients With Ischemic Cardiomyopathy (EPIC-VT)	N/A
Completed	`NCT03857906` - Evaluation of Prophylactic Use of a Preoperative IABP in High-Risk Coronary Artery Bypass Graft Surgery
Completed	`NCT02501811` - Combination of Mesenchymal and C-kit+ Cardiac Stem Cells as Regenerative Therapy for Heart Failure	Phase 2
Recruiting	`NCT02058771` - Utilising Lifemap to Investigate Malignant Arrhythmia Therapy
Not yet recruiting	`NCT01946048` - Umbilical Cord Derived Mesenchymal Stem Cells Therapy in Ischemic Cardiomyopathy	Phase 1
Terminated	`NCT01759212` - Left Ventricular Assist Device Combined With Allogeneic Mesenchymal Stem Cells Implantation in Patients With End-stage Heart Failure.	Phase 2/Phase 3
Not yet recruiting	`NCT01447069` - Use of Beta-agonists in Stable Severe Congestive Heart Failure	N/A
Recruiting	`NCT00972114` - CABG Combined Pedicled Omentum Wrapped Autologous Atrial Tissue Patch Cardiomyoplasty for Ischemic Cardiomyopathy	Phase 1/Phase 2
Completed	`NCT00896142` - Optima Coronary Artery Disease (CAD) (Optimal Mechanical Evaluation)	N/A
Recruiting	`NCT01076660` - Left Ventricular Structural Predictors of Sudden Cardiac Death
Completed	`NCT00305240` - MASTER I - Microvolt T Wave Alternans Testing for Risk Stratification of Post MI Patients	N/A
Completed	`NCT00305214` - MASTER II - Microvolt T Wave Alternans Testing for Risk Stratification of Post MI Patients	N/A
Active, not recruiting	`NCT00962364` - Long-term Evaluation of Patients Receiving Bone Marrow-derived Cell Administration for Heart Disease
Recruiting	`NCT05769036` - Conventional Biventricular Versus Left Bundle Branch Pacing on Outcomes in Heart Failure Patients	N/A
Completed	`NCT03862339` - The SoundScar Study The SOUNDSCAR Study